Skip to main content
Clinical Trials/ACTRN12624000407594
ACTRN12624000407594
Not yet recruiting
未知

Investigating the effectiveness of mindfulness meditation and clinical hypnosis for injury-related pain management in competitive athletes: A replicated single-case experimental design

The University of Queensland0 sites18 target enrollmentApril 3, 2024

Overview

Phase
未知
Intervention
Not specified
Conditions
Pain, Acute
Sponsor
The University of Queensland
Enrollment
18
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
April 3, 2024
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • a) be a competitive athlete (i.e., compete at a level beyond recreational or casual participation. This includes athletes who participate in regional, national, or international competitions, and those who are members of competitive teams or clubs),
  • b) currently have a sport or exercise\-related injury that resulted in an average pain
  • intensity greater than or equal to 3 on a 0\-10 numerical rating scale in the past
  • week, and for which the predicted recovery time at the point of study enrolment is
  • greater than 5 weeks
  • c) be 18 years of age or over,
  • d) read, speak, and understand the English language,
  • e) have access to the internet on a computer or smartphone,
  • f) have access to a set of earphones,
  • g) be willing to be randomly assigned to both conditions and listen to five 20\-minute treatment sessions (one per day),

Exclusion Criteria

  • a) Current alcohol or substance dependence;
  • b) Pain condition for which surgery has been recommended and is planned;
  • c) Current or past participation in a research study with treatment components that may overlap those in the current study;
  • d) Current or history of diagnosis of primary psychotic or major thought disorder within the past 5 years;
  • e) Psychiatric hospitalization within the past 6 months;
  • f) Psychiatric or behavioural conditions in which symptoms were unstable or severe within the past 6 months;
  • g) Active malignancy (e.g., cancer not in remission), terminal illnesses, or serious medical conditions that may interfere with either study participation or with receiving potential treatment benefits (e.g., severe lupus).

Outcomes

Primary Outcomes

Not specified

Similar Trials